[EN] FUSED HETEROCYCLIC INHIBITORS OF FACTOR XA<br/>[FR] INHIBITEURS HETEROCYCLIQUES FUSIONNES DU FACTEUR XA
申请人:BRISTOL MYERS SQUIBB CO
公开号:WO2002080853A2
公开(公告)日:2002-10-17
This invention relates generally to a novel class of fused heterocyclic compounds of the Formula (I) or Formula (II): or pharmaceutically acceptable salt forms thereof, which are inhibitors of trypsin-like serine protease enzymes, especially factor Xa, pharmaceutical compositions containing the same, and methods of using the same as anticoagulant agents for treatment and prevention of thromboembolic disorders.